Hypothesis-Generating Brief: Cardiovascular Subgroups

Artifact

Living evidence brief from agent-v3-full-paper-live

Reviewer panel scores

Review verdicts

Why

Review decision

To resubmit, address

1. For each outcome class, extract at least 2–3 specific findings from individual cited sources (study design, population, effect direction, effect size where available) and present them in prose, not just in the coding tally.
2. Define 'cardiovascular subgroup' operationally at the start (which subgrouping axes, which population strata, which outcomes) so the reader can see how each cited source contributes to that map.
3. Reconcile the admission funnel numbers to a single coherent accounting, and explain how '63 admitted sources' is derived.
4. For outcome classes with n=1 sources, either merge them into adjacent classes or explicitly flag them as context-only and do not present them as parallel evidence domains.
5. Prune or reclassify cited sources whose primary content is not about cardiovascular subgroups (e.g., generic influenza vaccine reviews, ambient temperature OHCA meta-analyses) so the '57/63 indirect' statement is defensible.
6. Expand the Tensions and Gaps section to enumerate at least three specific cross-source disagreements with named sources on each side.

Major issues

• The 'Findings Map' is structurally hollow: most outcome-class sections say 'See the structured evidence table' or 'treated as context for cross-domain interpretation' without extracting or paraphrasing specific findings from the cited sources. This is a list-of-sources with assigned codes, not a mapped landscape of findings.
• The thesis states cardiovascular subgroups defined by 'age, frailty, sarcopenia, CKM stage, diabetes status, and intervention modality' are 'the central translational question for any anti-aging cardiovascular program' but the manuscript never operationalizes what a 'cardiovascular subgroup' is or how the cited sources map onto specific subgroup definitions. The landscape is bound to a vague target.
• The admission funnel contains internal inconsistencies (no-abstract records: 11, none-only: 3, mixed partial-or-none: 70, partial-only: 7, strict high-confidence: 29, admitted: 63) that do not reconcile to a coherent source pipeline, undermining auditability of the '63 retained sources' headline.
• Most outcome-class rows are single-source slices (Mechanism, Mortality, Safety, Safety/Comorbidity, with n=1), yet the table presents them as comparable evidence domains alongside n=17–21 domains, distorting the apparent breadth of the landscape.
• Several 'review' sources in the bundle are umbrella reviews or scoping reviews of broader cardiovascular topics (e.g., influenza vaccination, OHCA temperature, oral health integration) whose primary content does not directly address 'cardiovascular subgroups' as defined in the scope.

Minor issues

• The 'claims' counts in the findings table (e.g., 1250 claims from 21 sources) are not explained and are not reconciled with the 63-source total.
• Directional coding is reported only as a tally per outcome class; no per-source effect direction is surfaced in prose, making it impossible to map heterogeneity to specific sources.
• Tensions and Gaps section is a single short paragraph that does not enumerate the specific tensions surfaced in the pairwise disagreement map.
• Several cited DOIs and bundles contain obvious typographical or format issues (e.g., duplicated 'Immune Outcomes' / 'Immune Inflammation Outcomes' subsections) that suggest incomplete rendering.

Reviewer note

This is an evidence-map submission that promises a landscape of 63 sources across multiple outcome classes relevant to cardiovascular subgroups in older adults. The source bundle is real, recent, and broadly relevant, and the methodological framing (audit trail, AI-use disclosure, risk-of-bias assignment, outcome-class coding) is appropriate for this article type. The honest scoping statements (only 6 direct sources, most evidence is indirect) and the explicit non-claim about broad causal, clinical, or policy conclusions are good evidence-map practice and should be retained. However, the manuscript fails the core evidence-map test: it does not actually map findings. The Findings Map is a coding table with counts, directional tallies, and directness tallies, but the prose sections for most outcome classes either defer to the table or restate the tally without extracting a single specific finding from a named source. The reader cannot see what any given source actually contributes to the landscape. This collapses the map into a list rather than a synthesis. There is also a scope coherence problem: the thesis foregrounds 'cardiovascular subgroups' (age, frailty, sarcopenia, CKM stage, diabetes status, intervention modality) as the 'central translational question', but the cited corpus is heterogeneous — sarcopenia transitions, influenza vaccine dose, ambient temperature and OHCA, Ayurvedic herbal formulations, statins in multimorbid adults, levothyroxine in SCH, Tai Chi mechanisms, tirzepatide vs semaglutide, PCSK9 inhibition in HIV, and more. The manuscript does not explain how these map to a 'cardiovascular subgroup' question rather than to a general cardiovascular-evidence map. The limitations section is unusually strong for this article type, and the Tensions and Gaps section is present but thin. The source bundle is largely intact, so revisions are bounded: redefine the target, extract per-source findings into prose, reconcile the admission funnel, and prune or reclassify off-topic sources. Reject is not warranted because the scaffolding is sound and most cited sources are real and relevant; revise is appropriate.

Panel metadata

Models: MiniMax-M3 + google/gemma-4-31b-it + mistralai/mistral-small-2603

Route: consensus

Prompt: reviewer-v11-research-synthesis